rs1554891075
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004329.3(BMPR1A):c.1010C>A(p.Ser337*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S337S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004329.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- generalized juvenile polyposis/juvenile polyposis coliInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Genomics England PanelApp
- juvenile polyposis syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
- polyposis syndrome, hereditary mixed, 2Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- hereditary mixed polyposis syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital heart defects, multiple typesInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- pulmonary arterial hypertensionInheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BMPR1A | NM_004329.3 | c.1010C>A | p.Ser337* | stop_gained | Exon 10 of 13 | ENST00000372037.8 | NP_004320.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BMPR1A | ENST00000372037.8 | c.1010C>A | p.Ser337* | stop_gained | Exon 10 of 13 | 1 | NM_004329.3 | ENSP00000361107.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.S337* pathogenic mutation (also known as c.1010C>A), located in coding exon 8 of the BMPR1A gene, results from a C to A substitution at nucleotide position 1010. This changes the amino acid from a serine to a stop codon within coding exon 8. A different nucleotide substitution (c.1010C>G) leading to the same p.S337* protein truncation has been identified in and individual diagnosed with juvenile polyposis syndrome (JPS) in childhood (Friedl W et al, Hum. Genet. 2002 Jul; 111(1):108-11). In addition to the clinical data presented in the literature, since premature stop codons are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Juvenile polyposis syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Ser337*) in the BMPR1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BMPR1A are known to be pathogenic (PMID: 11536076, 12417513). This variant is not present in population databases (ExAC no frequency). This nonsense change has been observed in individual(s) with juvenile polyposis syndrome (PMID: 12136244). ClinVar contains an entry for this variant (Variation ID: 486799). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at